Recently, Alibaba Health’s medical AI platform, ‘Hydrogen Ion,’ announced that it has forged content partnerships with the NEJM Group (publisher of The New England Journal of Medicine), JAMA (Journal of the American Medical Association), and the JAMA Network. Coupled with its prior agreement with the BMJ Group (British Medical Journal), Hydrogen Ion now stands as the first medical AI platform in China to secure full-text content rights from these three premier global medical journals.
